ArticleMicrobiology spectrum2025
Genotypic characterization of extended-spectrum beta-lactamase-producing
Marco Werhahn Beining, Sebastian Guenther, Antina Lüebke-Becker, Stefan E Heiden, Katharina Schaufler, Lothar Kreienbrock, Michael Schwabe
Abstract read
In one paragraphArticle in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Marco Werhahn BeiningInstitute of Biometry, Epidemiology and Information Processing, WHO-Collaborating Center for Research and Training in Veterinary Public Health, University of Veterinary Medicine, Hannover, Germany.ORCID 0009-0004-3993-0974 Sebastian GuentherPharmaceutical Biology, Institute of Pharmacy, University of Greifswald, Greifswald, Germany.
Antina Lüebke-BeckerCenter for Infection Medicine, Institute of Microbiology and Epizootics, Freie Universität Berlin, Berlin, Germany.
Stefan E HeidenEpidemiology and Ecology of Antimicrobial Resistance, Helmholtz Institute for One Health, Helmholtz Center for Infection Research HZI, Greifswald, Germany.
Katharina SchauflerEpidemiology and Ecology of Antimicrobial Resistance, Helmholtz Institute for One Health, Helmholtz Center for Infection Research HZI, Greifswald, Germany.ORCID 0000-0002-2669-8799 Lothar KreienbrockInstitute of Biometry, Epidemiology and Information Processing, WHO-Collaborating Center for Research and Training in Veterinary Public Health, University of Veterinary Medicine, Hannover, Germany.
Michael SchwabeEpidemiology and Ecology of Antimicrobial Resistance, Helmholtz Institute for One Health, Helmholtz Center for Infection Research HZI, Greifswald, Germany.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Antimicrobial resistance (AMR) is a growing concern in veterinary and public health, with extended-spectrum beta-lactamase (ESBL)-producing
Indexed as
beta-LactamasesDog DiseasesEscherichia coliEscherichia coli InfectionsAnimalsAnti-Bacterial AgentsDogsDrug Resistance, Multiple, BacterialEscherichia coli ProteinsGenotypeGermanyMicrobial Sensitivity TestsMultilocus Sequence TypingPhylogenyPolymorphism, Single NucleotideVirulence FactorsAnti-Bacterial Agentsbeta-LactamasesEscherichia coli ProteinsVirulence Factorsantibiotic resistancebeta-lactamasedrug resistanceESBL Escherichia coli
Identifiers
PMID40401964
PMCPMC12211048
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390